Nihal Gurusinghe
Nihal Trevor Gurusinghe is a British neurosurgeon who has worked in the National Health Service (NHS) since December 1975, completing 50 years of NHS service in December 2025.
≈ 3 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
Nihal Trevor Gurusinghe is a British neurosurgeon who has worked in the National Health Service (NHS) since December 1975, completing 50 years of NHS service in December 2025. He has served as a consultant neurosurgeon at the Lancashire Teaching Hospitals NHS Foundation Trust and is an honorary professor at the University of Central Lancashire. He was appointed a Member of the Order of the British Empire (MBE) in the 2023 New Year Honours.
Sydney Driscoll Neuroscience Foundation
Gurusinghe is the founder of the Sydney Driscoll Neuroscience Foundation, a registered charity established in 19891 to support neuroscience education and research at Preston. He served as chairman from 1989 to 2006 and has continued as a trustee. Since 2018, Gurusinghe has chaired the Oversight Group governing the brain-cancer research collaboration between the foundation and the University of Lancashire.
Research
Gurusinghe's research has focused primarily on clinical neurosurgery, with particular emphasis on neurovascular disorders, spinal tumours, intracranial aneurysms, cavernous malformations, and meningiomas. His work has included studies on aneurysmal subarachnoid haemorrhage, including radiological grading and the prediction of cerebral vasospasm, as well as the development of regional neurovascular services in the North West of England.
He has published on intracranial and spinal tumours, including long-term follow-up studies of benign tumours and investigations into meningioma growth and recurrence. Gurusinghe has contributed to research on cavernous malformations and vascular anomalies, including case series and systematic reviews.
He has also co-authored work on small unruptured intracranial aneurysms, including meta-analyses examining radiological surveillance strategies. In collaboration with researchers at the University of Central Lancashire, he has participated in translational research projects investigating spectroscopic and computational methods for the characterisation and grading of meningioma tumours, including the use of Raman microspectroscopy and attenuated total reflectance Fourier-transform infrared spectroscopy (ATR-FTIR).
He has served as a local principal investigator for national multicentre clinical trials, including the Trial of Dexamethasone for Chronic Subdural Haematoma, the results of which were published in the New England Journal of Medicine in 20201, and the CARE Cavernoma Trial UK.
Honours
Gurusinghe is a member of the British Medical Association, the Neurosurgical Association of Sri Lanka and the Society of British Neurological Surgeons. He is also a Fellow of the Royal College of Surgeons of Edinburgh. In 2023, he was appointed Member of the Order of the British Empire (MBE) in the King's New Year Honours.
In September 2024, Gurusinghe received the Society of British Neurological Surgeons Medal at the society's meeting in Birmingham in recognition of his contributions to the SBNS and neurosurgery. In February 2025, Gurusinghe received a Lifetime Achievement Award from the Neurosurgeons Association of Sri Lanka in recognition of his contribution to the support and development of neurosurgery in Sri Lanka.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1377285072 under CC BY-SA 4.0; modifications have been made.
References
- ↩Wikipedia “Nihal Gurusinghe” date of establishment (×2) · confidence 0.95 revision URL